Connect with us

Cannabis News

The Fight For Cannabis Reform Must Focus On Medical Patients—Not Taxes And Banking—In Order To Win (Op-Ed)

Published

3 months ago

on

“Without medicine at the center, the Federal reform loses its moral compass and its political lever.”

Cannabis Businesses and Professionals Unity for the National Medical Kannabis

It is clear that the opposition against cannabis is nourished by the narrative of moral panic, disinformation and “large marijuana”. Without strategic contracting for well-being, we risk losing the land we have earned.

Last week, the HOUSE’s paving committee exceeded the version of the Budget of the Department of Justice. FY2026 Trade, Justice, Science and Related Agency (CJS) would include provisions that will allow the administration of drug enforcement administration (DEA) again in the states of cannabis programs.

CJS Budget Bill was the language that would also want Prevent President Donald Trump to make efforts for determination in cannabis programming. This should turn off alarms in our community. And yet the loudest push came from business, but from patients, with our uncompromise, farms, allies.

Our most valuable asset

The coverage coverage coverage for Kannabis was a promise to produce “determination” for a few weeks. But there was a real bearer What he said about Kannabis: “great thing about medicine” listens.

These words catch true in Washington, DC: Cannabis doctor remains the most politically feasible policy for federal policy reform. If you currently face cannabis businesses and professionals, we cannot ignore the truth.

Bank and tax relief will not come with a great reform of cannabis

Despite the flood of new State laws, new businesses and new participants, Washington barely made.

It has been more than a decade to secure access to Secure access (ASA) to ensure the fire interference in the Medical State of Congress. Bank reform, tax fairness and state trade are still not available. Patients remain access to stigma, discrimination and patches.

Corporate Kornabis seemed to be supported by the medical expansion and cannabis business, who walks far from the patient’s narrative. It was the descendant of the Department of Health and Human Services (HHS), Cannabis “admits that he currently supports” medical use “and will lead to the III program.

Instead of taking a return of victory for medical cannabis, the cannabis community was based on tax deductions.

This pivot has been able to provide short-term growth and attention, but he actually canceled the proven path that has moved Congress: patients. The result is a decade of Washington.

Without a medical cannabis in the center, the Federal reform loses its moral compass and a political lever.

Including the “big things” about medical cannabis

Medical cannabis is the strongest counterpoint. It saves lives, reduces health costs and undergo public support during the political spectrum.

Consider the numbers:

  • Chronic pain: Almost 30% of chronic pain patients use cannon to relieve, often reduce or replace opioids. More than 68 million Americans live with chronic pain.
  • Cancer: More than 40% of cancer reports the symptoms such as pain, anxiety, sleep and hunger.
  • Older adults: One of the five adults now uses cannabis now. In the medical states, many advantages made by many arthritis, sleep and quality of life. It is the fastest increase in Kannabis users.
  • Veterans: About 22 percent of veterans use PTSD, chronic pain and sleeping incidents, still facing stigma and federal obstacles.
  • Opioids: Washington Post recently mentioned the study County with dispensers will be seen reducing 30 percent of the dead Opioido overdose over time.

Pay page

If you entered the Kannabis space in the last five years or 10 years, you may not know how we arrived.

Patient advocates have been working on strategies for decades for the National Medical Canavy Program.

For years, the cannabis supply chain programs, cannabis supply chain products, the World Cannabis Organization (UN) and the United Nations, and the United Nations, recommends patients for medical professionals.

White House This year decreased these protections, Asa called the organizations of national patients and encouraged Congress to restore them. And HHS can Cannabis “use medical use” at this time? Reflects more than two decades established by patient defenders.

Not to choose zero sum

Helping Medical Kannabis does not mean against adult use. In fact, focusing the doctor strengthens the whole market.

Patients bring credibility with politicians, their stories create support for bipartisan and their experiences cannot be divided into quarter sales figures.

President Trumpen comments – “Great things about doctors” – they are not just a note. In the policy of Kannabis, they reflect coherent thread in administrations, festivals and decades: the medical cannabis has had power.

If we become “great things”, we can change the conversation, go back and finally, we will finally get comprehensive federal realms of patients.

Patients have a plan; They need our help

As a creative founder of safe access, Steph Sherer described the last marijuana at the moment. “It’s time for the congress to create a federal path for medical cannabis accesses” The next phase of access is a comprehensive federal legislation. History has shown us that the doctor must first come.

Patients created a moral and political basis for cannabis reform. Today they remain the strongest motor. But only patients cannot carry this fight. If we want to move Washington, we need to put patients and their needs behind our efforts.

Cannabis businesses and professionals united for the national medical cannabis It is safe access to access security (ASA) interested business, professionals and investors who believe in cannabis medicine and are willing to end the patients.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

(Tagstotranslate) highlighted

Related Topics:
Continue Reading

Cannabis News

By concentrating our portfolio, we create room for innovation and growth

Published

12 hours ago

on

December 8, 2025

By






Viscon transfers the range fork product portfolio to Flier






Viscon Plant Technology will transfer its spacer fork product portfolio (including spacer forks and fixed forks) to Flier Systems effective January 1, 2026.

“The furrows are a proven solution for spacing within the sector. By transferring this portfolio to Flier Systems, the technology will remain available to both existing and new customers, with continued quality and support. Flier Systems will take over development, sales and technical service, while Viscon Plant Technology focuses on its core activities,” the team says.

© Viscon

“The transfer of the fields is a deliberate strategic step to strengthen our focus on automation solutions for plant growers and young breeders. In addition to concentrating our portfolio on technologies such as tissue culture automation, phenotypic sorting and somatic embryogenesis automation, we create room for further innovation and growth. We are pleased to have found a reliable and dedicated partner in Flier Systems,” said Nigela, who will continue the same product portfolio. Viscon Plant Technology.

“Acquiring spacer forks fits perfectly into our strategy to automate the entire production process for professional plant growers. Having just introduced the upgraded SPH transplanter/sorter, we have already taken an important step in the automation of potted plants. Acquiring spacer forks is a logical addition as it allows us to offer a complete and integrated package. Viscon,” said Ad Kranendonk, Flier Systems.



Publication date:













Continue Reading

Cannabis News

Michigan Judge Allows Marijuana Tax Increase To Take Effect Despite Industry Lawsuit

Published

12 hours ago

on

December 8, 2025

By

Cannabis industry groups argued that the tax violates the state Constitution by amending a voter-approved legalization law without following due process.

By: Ben Solis, Michigan Advance

A group of cannabis industry advocates failed to convince a Michigan Court of Claims judge that it would suffer irreparable harm. A new 24 percent wholesale tax on marijuana went into effect To fund future road repairs in the state.

In an opinion issued Monday, Court of Claims Judge Sima Patel said Holistic Research Group Inc./Michigan Cannabis Industry v. That the Michigan Department of Finance was denying plaintiffs’ request for a preliminary injunction.

The joint lawsuits said the new tax was approved in October as part of a comprehensive budget deal for 2025-26. Raising new revenue for road repair and reconstruction Until 2030, because it was against the Constitution violated the title-object clause of the state Constitution.

Patel said Monday, after hearing oral arguments on the case in November, that the industry’s advocates had failed to argue that there was a genuine constitutional issue, nor had the group briefly shown that the Michigan Marijuana Regulation and Taxation Act, which legalized the use and sale of cannabis in Michigan, was the only legal mechanism for taxing the flower.

“(The road funding act) is consistent (with the marijuana tax law). Plaintiffs say the phrase ‘all other taxes’ … refers only to generally applicable taxes, like the 6 percent sales tax imposed on all retail sales,” he wrote. “If that were true, however, the initiative could have simply said that. Instead, the initiative clearly stated that the 10 percent retail excise tax was in addition to ‘all other taxes.’

Patel also pointed out that the Legislature did not directly change any of the existing taxes in the regulatory act, nor replace them with the new tax in the road funding legislation; rather, the Legislature established a new separate tax, which is allowed under the governing law.

“The two statutes can be read together,” Patel wrote.

So the claim about the mechanism by which a new tax could be imposed was dismissed, Patel wrote.

Patel, however, allowed the case to go forward to determine whether the tax interferes with the intent of the voter-initiated law that allowed the consumption, regulation and sale of marijuana. Patel said there remained a genuine issue in the matter, which required further consideration by the court.

“The court must consider the intentions of the (tax act) drafters and the effect of the new wholesale excise tax on the (tax law’s) objectives,” Patel wrote. “The court will not be able to resolve these questions of fact at the summary disposition stage. Discovery will be necessary to develop the evidence necessary to support the parties’ positions.”

This story was first published by the Michigan Advance.

Photo elements courtesy of the user rawpixel and Philip Steffan.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

HoneyGrove Dispensary selivers affordable small-batch flower to patients amid push for MMJ reform

Published

1 day ago

on

December 7, 2025

By











HoneyGrove Dispensary has partnered with Ewing-based medical cannabis company Noble Valley Harvest Company to offer small-batch flowers at reduced prices to medical marijuana patients.

Half ounces are available for $75 and full ounces are available for $125, with no sales tax applied to cardholder purchases. HoneyGrove waives sales tax on adult-use transactions for patients with a valid medical card to support patient access.

Within NJ’s three-ounce monthly purchase limit, cardholders can get $100 off multiple ounce purchases.

© Rey Fernandez

The initiative addresses ongoing concerns about affordability in New Jersey’s medical marijuana program, which has drawn criticism for high costs and limited supply. By offering premium, small-batch products at prices associated with lower-quality options, HoneyGrove and Noble Valley aim to improve immediate patient access while advocating for broader program reforms.

“HoneyGrove and HoneyStash are committed to patient care by partnering with local growers,” said Dave Valese, CEO of HoneyProjects, the management company for both dispensaries. “This partnership with Noble Valley ensures that medical patients receive high-quality flower at affordable prices, supporting our broader efforts to improve New Jersey’s medical cannabis program.”

“Noble Valley Harvest is producing small-batch cannabis for the New Jersey market,” said Dr. Lisa Grega, founder of Noble Valley Harvest Company. “We’re excited to give medical patients first access to help boost a market that’s shrinking in size and selection.”

For more information:
Honey Projects
honey-projects.com



Publication date:













Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media